Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+221K
-
Total reported value, excl. options
-
$230M
-
Value change
-
-$6.99M
-
Put/Call ratio
-
1.02
-
Number of buys
-
50
-
Number of sells
-
-47
-
Price
-
$8.07
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q1 2016
124 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q1 2016.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 386M outstanding shares and own 7.39% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (4.27M shares), WASATCH ADVISORS INC (2.65M shares), LEVIN CAPITAL STRATEGIES, L.P. (2.09M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2.06M shares), FRANKLIN RESOURCES INC (2M shares), ORBIMED ADVISORS LLC (1.75M shares), JENNISON ASSOCIATES LLC (1.2M shares), RUSSELL FRANK CO/ (1.13M shares), VANGUARD GROUP INC (1.06M shares), and WELLINGTON MANAGEMENT GROUP LLP (961K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.